Gabelli Funds’s Pacific Biosciences PACB Stock Holding History

Gabelli Funds’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Hold	100,000	–	–	﹤0.01%	1187
2026 Q1	$132K	Hold	100,000	–	–	﹤0.01%	1172
2025 Q4	$187K	Hold	100,000	–	–	﹤0.01%	1158
2025 Q3	$128K	Hold	100,000	–	–	﹤0.01%	1170
2025 Q2	$124K	Hold	100,000	–	–	﹤0.01%	1162
2025 Q1	$118K	Hold	100,000	–	–	﹤0.01%	1037
2024 Q4	$183K	Hold	100,000	–	–	﹤0.01%	1023
2024 Q3	$170K	Hold	100,000	–	–	﹤0.01%	1022
2024 Q2	$137K	Hold	100,000	–	–	﹤0.01%	1015
2024 Q1	$375K	Hold	100,000	–	–	﹤0.01%	922
2023 Q4	$981K	Hold	100,000	–	–	0.01%	782
2023 Q3	$835K	Hold	100,000	–	–	0.01%	825
2023 Q2	$1.33M	Hold	100,000	–	–	0.01%	745
2023 Q1	$1.16M	Hold	100,000	–	–	0.01%	774
2022 Q4	$818K	Hold	100,000	–	–	0.01%	842
2022 Q3	$581K	Sell	100,000 -8,302	-8%	-$47.6K	﹤0.01%	947
2022 Q2	$479K	Sell	108,302 -94,698	-47%	-$575K	﹤0.01%	1028
2022 Q1	$1.85M	Hold	203,000	–	–	0.01%	741
2021 Q4	$4.15M	Buy	+203,000	New	+$4.9M	0.03%	557
2020 Q4	–	Sell	-276,000	Closed	-$2.72M	–	1229
2020 Q3	$2.72M	Sell	276,000 -2,064,887	-88%	-$11.9M	0.02%	598
2020 Q2	$8.08M	Sell	2,340,887 -27,000	-1%	-$91.9K	0.07%	340
2020 Q1	$7.25M	Sell	2,367,887 -72,011	-3%	-$295K	0.06%	339
2019 Q4	$12.5M	Sell	2,439,898 -357,361	-13%	-$1.82M	0.08%	295
2019 Q3	$14.4M	Sell	2,797,259 -60,486	-2%	-$338K	0.1%	274
2019 Q2	$17.3M	Sell	2,857,745 -42,361	-1%	-$297K	0.11%	245
2019 Q1	$21M	Buy	2,900,106 +1,155,636	+66%	+$8.36M	0.13%	216
2018 Q4	$12.9M	Buy	+1,744,470	New	+$11.1M	0.09%	298

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Gabelli Funds's PACB Position: Q2 2026 in Review

Gabelli Funds held its Pacific Biosciences (PACB) position steady in Q2 2026 at 100,000 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

Gabelli Funds first reported a position in PACB in Q4 2018 and has held it in 27 quarters since. The position peaked at $21M in Q1 2019. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Gabelli Funds held 100,000 shares of Pacific Biosciences worth $168K as of Q2 2026.
Gabelli Funds left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1187 holding.
Gabelli Funds first reported a position in Pacific Biosciences in Q4 2018 and has held it in 27 quarters since.
Gabelli Funds's Pacific Biosciences position peaked at $21M in Q1 2019.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.